LOS ANGELES, July 01, 2025 (GLOBE NEWSWIRE) -- The Wonderful Company, one of the most philanthropic companies in the United States, is pleased to announce that its $1 million Wonderful Central Valley Community Grants application period is now live. Over the past 10 years, The Wonderful Company and its co-owners, Lynda and Stewart Resnick, along…
DebitMyData™ Logo FORT LAUDERDALE, Fla., Dec. 28, 2025 (GLOBE NEWSWIRE) -- As AI accelerates beyond human employment capacity and public trust erodes under massive data center expansion, DebitMyData, Inc. is building the missing bridge — the human and digital foundation for the next economy.
Austin, TX , Dec. 27, 2025 (GLOBE NEWSWIRE) -- Celebrate Dental & Braces South Austin is expanding access to affordable Invisalign and comprehensive family dental care for Austin residents through its South Congress location. As more families seek convenient and cost effective orthodontic and dental solutions the practice is responding by offering flexible treatment options…
Beijing, China, Dec. 27, 2025 (GLOBE NEWSWIRE) -- Among the many descriptions of China seen from the outside, the country has gained an increasingly prominent image for itself in 2025 as a "cool" place to visit and live, as reflected in multiple global surveys and in foreign vloggers' videos and comments.
NEW YORK, Dec. 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) between February 21, 2025 and August 28, 2025, both dates inclusive (the “Class Period”), of the important January 9, 2026 lead plaintiff deadline in the securities class…
New York City, NY, Dec. 27, 2025 (GLOBE NEWSWIRE) -- Maintaining a healthy weight is a multifaceted issue that numerous individuals in the United States grapple with. Despite attempting various conventional weight loss approaches, satisfactory outcomes are frequently elusive, leading individuals to explore alternative options. However, in recent years, glucagon-like peptide-1 (GLP-1) agonists have emerged…
